Date of event: estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Implant date: estimated.The device was not returned for evaluation.The lot history record (lhr) for this product could not be reviewed and a similar complaint query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.The reported patient effects of restenosis and claudication are listed in the supera instructions for use as known potential adverse patient effects of peripheral percutaneous intervention.Based on the information provided, a definitive cause for the difficulties and subsequent patient effects could not be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that around (b)(6) 2017, during implantation of a supera stent, the stent may have elongated.In (b)(6) 2019, the patient experienced claudication.Per doppler, the stent was noted to be restenosed.Sometime later, atherectomy was performed and flow was re-established.There was no additional information provided.
|